{"id":27805,"date":"2021-02-22T12:00:00","date_gmt":"2021-02-22T18:00:00","guid":{"rendered":"https:\/\/goldenti.com\/site\/?p=27805"},"modified":"2021-02-22T11:03:31","modified_gmt":"2021-02-22T17:03:31","slug":"gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas","status":"publish","type":"post","link":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/","title":{"rendered":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas"},"content":{"rendered":"\n

La primera vacuna desarrollada por GSK y Sanofi no tuvo una respuesta inmunitaria insuficiente en personas mayores; probar\u00e1n con otra.<\/em><\/p>\n\n\n\n

\"vacuna
Foto: Reuters.<\/figcaption><\/figure>\n\n\n\n

Reuters.-<\/strong> La brit\u00e1nica GlaxoSmithKline y la francesa Sanofi anunciaron este lunes que hab\u00edan iniciado un nuevo ensayo cl\u00ednico de su candidata a vacuna para Covid-19, basada en prote\u00ednas, y que pretenden llegar a la fase final de pruebas en el segundo trimestre del a\u00f1o.<\/p>\n\n\n\n

Si los resultados son concluyentes, las farmac\u00e9uticas esperan que la vacuna se apruebe en el cuarto trimestre, despu\u00e9s de haber apuntado inicialmente al primer semestre de este a\u00f1o.<\/p>\n\n\n\n

La decisi\u00f3n se da despu\u00e9s de que los fabricantes de medicamentos dijeran en diciembre que su vacuna se retrasar\u00eda debido a que los ensayos cl\u00ednicos hab\u00edan mostrado una respuesta inmunitaria insuficiente en personas mayores.<\/p>\n\n\n\n

El nuevo ensayo tendr\u00e1 como objetivo evaluar la seguridad, la tolerabilidad y la respuesta inmunitaria de la vacuna en 720 adultos sanos de Estados Unidos, Honduras y Panam\u00e1, dijeron las empresas.<\/p>\n\n\n\n

El candidato de Sanofi y GSK utiliza la misma tecnolog\u00eda basada en prote\u00ednas recombinantes que una de las vacunas contra la gripe estacional de Sanofi. Se combinar\u00e1 con un adyuvante, una sustancia que act\u00faa como refuerzo de la inyecci\u00f3n, fabricado por GSK.<\/p>\n\n\n\n

El estudio probar\u00e1 dos inyecciones administradas con 21 d\u00edas de diferencia. <\/p>\n\n\n\n

Sanofi ayudar\u00e1 a Johnson & Johnson<\/h2>\n\n\n\n

Sanofi tambi\u00e9n dio a conocer este lunes que brindar\u00e1 apoyo para la fabricaci\u00f3n de la vacuna para Covid-19 a la estadounidense Johnson & Johnson.<\/p>\n\n\n\n

Una vez autorizado, Sanofi proporcionar\u00e1 a J&J acceso a la infraestructura establecida y la experiencia de su planta de fabricaci\u00f3n de vacunas en Marcy l\u2019Etoile, Francia, para formular y llenar viales de la vacuna candidata Janssen COVID-19 de J&J. en 2021, a una tasa de aproximadamente 12 millones de dosis por mes.<\/p>\n\n\n\n

Fuente:<\/strong> https:\/\/www.forbes.com.mx\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La primera vacuna desarrollada por GSK y Sanofi no tuvo una respuesta inmunitaria insuficiente en personas […]<\/p>\n","protected":false},"author":13,"featured_media":27806,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-27805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticas"],"yoast_head":"\nGSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -\" \/>\n<meta property=\"og:description\" content=\"La primera vacuna desarrollada por GSK y Sanofi no tuvo una respuesta inmunitaria insuficiente en personas […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-22T18:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png\" \/>\n\t<meta property=\"og:image:width\" content=\"858\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas\",\"datePublished\":\"2021-02-22T18:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\"},\"wordCount\":338,\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png\",\"articleSection\":[\"Noticas\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\",\"url\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\",\"name\":\"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png\",\"datePublished\":\"2021-02-22T18:00:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage\",\"url\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png\",\"contentUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png\",\"width\":858,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/goldenti.com\/site\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/goldenti.com\/site\/#website\",\"url\":\"https:\/\/goldenti.com\/site\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/goldenti.com\/site\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/goldenti.com\/site\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/","og_locale":"es_ES","og_type":"article","og_title":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -","og_description":"La primera vacuna desarrollada por GSK y Sanofi no tuvo una respuesta inmunitaria insuficiente en personas […]","og_url":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/","article_published_time":"2021-02-22T18:00:00+00:00","og_image":[{"width":858,"height":480,"url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#article","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/"},"author":{"name":"","@id":""},"headline":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas","datePublished":"2021-02-22T18:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/"},"wordCount":338,"image":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png","articleSection":["Noticas"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/","url":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/","name":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas -","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage"},"image":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png","datePublished":"2021-02-22T18:00:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#primaryimage","url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png","contentUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/Captura-77.png","width":858,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/goldenti.com\/site\/gsk-y-sanofi-inician-pruebas-de-nueva-vacuna-basada-en-proteinas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/goldenti.com\/site\/"},{"@type":"ListItem","position":2,"name":"GSK y Sanofi inician pruebas de nueva vacuna basada en prote\u00ednas"}]},{"@type":"WebSite","@id":"https:\/\/goldenti.com\/site\/#website","url":"https:\/\/goldenti.com\/site\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/goldenti.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"","url":"https:\/\/goldenti.com\/site\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/comments?post=27805"}],"version-history":[{"count":1,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27805\/revisions"}],"predecessor-version":[{"id":27807,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27805\/revisions\/27807"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media\/27806"}],"wp:attachment":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media?parent=27805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/categories?post=27805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/tags?post=27805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}